Hasil Pencarian  ::  Simpan CSV :: Kembali

Hasil Pencarian

Ditemukan 2 dokumen yang sesuai dengan query
cover
Wilia Candra
"ABSTRAK
Hipertensi merupakan kelainan yang umum dijumpai pada kehamilan.
Sekitar 70% wanita hamil mengalami gestational hypertension dan preeklampsia.
Disfungsi endotel pada preeklampsia menyebabkan permukaan endotel yang
nontrombogenik menjadi trombogenik sehingga dapat terjadi aktivasi koagulasi.
Preeklampsia meningkatkan keadaan hiperkoagulabel yang sudah ada pada
kehamilan normal. Gestational hypertension pada wanita hamil adalah hipertensi
yang tidak memenuhi kriteria preeklampsia. Hampir setengah dari pasien dengan
gestational hypertension akan berkembang menjadi preeklampsia. Fibrin
monomer merupakan petanda aktivasi koagulasi yang digunakan pada keadaan
pretrombotik oleh karena terbentuk terlebih dahulu pada keadaan hiperkoagulabel
daripada D-dimer yang terbentuk setelah fibrinolisis. Tujuan penelitian adalah
mendapatkan gambaran fibrin monomer pada gestational hypertension dan
preeklampsia. Penelitian ini adalah penelitian potong lintang pada 30 wanita
hamil gestational hypertension dan 30 wanita hamil preeklampsia yang dilakukan
pada Oktober sampai November 2015. Pemeriksaan FM menggunakan reagen
STA-Liatest memakai koagulometer STA Compact Analyzer. Kadar fibrin
monomer pada gestational hypertension didapatkan mean 4,61 µg/mL dengan
standar deviasi 0,86 µg/mL. Kadar fibrin monomer pada preeklampsia didapatkan
median 10,5 µg/mL dengan mean 11.99 µg/mL dan rentang 6,12 ? 23,26 µg/mL.
Didapatkan perbedaan bermakna kadar fibrin monomer pada gestational
hypertension dan preeklampsia dengan nilai p<0,001.
ABSTRACT
Hypertension is a common disorder in pregnancy. Approximately 70% of
pregnant women is gestational hypertension and preeclampsia. Endothelial
dysfunction in preeclampsia causes the endothelial surface of the nonthrombogenic
be thrombogenic so it can activated coagulation. Preeclampsia
increase hypercoagulability state in normal pregnancy. Gestational hypertension is
a hypertension in pregnancy who do not meet the criteria of preeclampsia. Nearly
half of patients with gestational hypertension develop into preeclampsia. Fibrin
monomers are used for coagulation activation marker on the prethrombotic state
therefore formed before on hypercoagulability state hiperkoagulabel than D-dimer
formed after fibrinolysis. The objective of this study is to gain description of
fibrin monomer levels and it was a cross-sectional study 30 pregnant women with
gestational hypertension and 30 pregnant women with preeclampsia. The study
was conducted in October and November 2015. Examination of fibrin monomer
using the reagent STA-Liatest and analyzer STA Compact. Mean of fibrin
monomer in gestational hypertension was 4.61 µg/mL with standard deviation
was 0.86 µg/mL. Median of fibrin monomer in preeclampsia was 10.5 µg / mL
with range was 6.12 to 23.26 µg/mL. Fibrin monomer levels found significant
differences in gestational hypertension and preeclampsia with p <0.001.
;Hypertension is a common disorder in pregnancy. Approximately 70% of
pregnant women is gestational hypertension and preeclampsia. Endothelial
dysfunction in preeclampsia causes the endothelial surface of the nonthrombogenic
be thrombogenic so it can activated coagulation. Preeclampsia
increase hypercoagulability state in normal pregnancy. Gestational hypertension is
a hypertension in pregnancy who do not meet the criteria of preeclampsia. Nearly
half of patients with gestational hypertension develop into preeclampsia. Fibrin
monomers are used for coagulation activation marker on the prethrombotic state
therefore formed before on hypercoagulability state hiperkoagulabel than D-dimer
formed after fibrinolysis. The objective of this study is to gain description of
fibrin monomer levels and it was a cross-sectional study 30 pregnant women with
gestational hypertension and 30 pregnant women with preeclampsia. The study
was conducted in October and November 2015. Examination of fibrin monomer
using the reagent STA-Liatest and analyzer STA Compact. Mean of fibrin
monomer in gestational hypertension was 4.61 µg/mL with standard deviation
was 0.86 µg/mL. Median of fibrin monomer in preeclampsia was 10.5 µg / mL
with range was 6.12 to 23.26 µg/mL. Fibrin monomer levels found significant
differences in gestational hypertension and preeclampsia with p <0.001.
;Hypertension is a common disorder in pregnancy. Approximately 70% of
pregnant women is gestational hypertension and preeclampsia. Endothelial
dysfunction in preeclampsia causes the endothelial surface of the nonthrombogenic
be thrombogenic so it can activated coagulation. Preeclampsia
increase hypercoagulability state in normal pregnancy. Gestational hypertension is
a hypertension in pregnancy who do not meet the criteria of preeclampsia. Nearly
half of patients with gestational hypertension develop into preeclampsia. Fibrin
monomers are used for coagulation activation marker on the prethrombotic state
therefore formed before on hypercoagulability state hiperkoagulabel than D-dimer
formed after fibrinolysis. The objective of this study is to gain description of
fibrin monomer levels and it was a cross-sectional study 30 pregnant women with
gestational hypertension and 30 pregnant women with preeclampsia. The study
was conducted in October and November 2015. Examination of fibrin monomer
using the reagent STA-Liatest and analyzer STA Compact. Mean of fibrin
monomer in gestational hypertension was 4.61 µg/mL with standard deviation
was 0.86 µg/mL. Median of fibrin monomer in preeclampsia was 10.5 µg / mL
with range was 6.12 to 23.26 µg/mL. Fibrin monomer levels found significant
differences in gestational hypertension and preeclampsia with p <0.001.
;Hypertension is a common disorder in pregnancy. Approximately 70% of
pregnant women is gestational hypertension and preeclampsia. Endothelial
dysfunction in preeclampsia causes the endothelial surface of the nonthrombogenic
be thrombogenic so it can activated coagulation. Preeclampsia
increase hypercoagulability state in normal pregnancy. Gestational hypertension is
a hypertension in pregnancy who do not meet the criteria of preeclampsia. Nearly
half of patients with gestational hypertension develop into preeclampsia. Fibrin
monomers are used for coagulation activation marker on the prethrombotic state
therefore formed before on hypercoagulability state hiperkoagulabel than D-dimer
formed after fibrinolysis. The objective of this study is to gain description of
fibrin monomer levels and it was a cross-sectional study 30 pregnant women with
gestational hypertension and 30 pregnant women with preeclampsia. The study
was conducted in October and November 2015. Examination of fibrin monomer
using the reagent STA-Liatest and analyzer STA Compact. Mean of fibrin
monomer in gestational hypertension was 4.61 µg/mL with standard deviation
was 0.86 µg/mL. Median of fibrin monomer in preeclampsia was 10.5 µg / mL
with range was 6.12 to 23.26 µg/mL. Fibrin monomer levels found significant
differences in gestational hypertension and preeclampsia with p <0.001.
;Hypertension is a common disorder in pregnancy. Approximately 70% of
pregnant women is gestational hypertension and preeclampsia. Endothelial
dysfunction in preeclampsia causes the endothelial surface of the nonthrombogenic
be thrombogenic so it can activated coagulation. Preeclampsia
increase hypercoagulability state in normal pregnancy. Gestational hypertension is
a hypertension in pregnancy who do not meet the criteria of preeclampsia. Nearly
half of patients with gestational hypertension develop into preeclampsia. Fibrin
monomers are used for coagulation activation marker on the prethrombotic state
therefore formed before on hypercoagulability state hiperkoagulabel than D-dimer
formed after fibrinolysis. The objective of this study is to gain description of
fibrin monomer levels and it was a cross-sectional study 30 pregnant women with
gestational hypertension and 30 pregnant women with preeclampsia. The study
was conducted in October and November 2015. Examination of fibrin monomer
using the reagent STA-Liatest and analyzer STA Compact. Mean of fibrin
monomer in gestational hypertension was 4.61 µg/mL with standard deviation
was 0.86 µg/mL. Median of fibrin monomer in preeclampsia was 10.5 µg / mL
with range was 6.12 to 23.26 µg/mL. Fibrin monomer levels found significant
differences in gestational hypertension and preeclampsia with p <0.001.
"
Fakultas Kedokteran Universitas Indonesia, 2016
SP-PDF
UI - Tugas Akhir  Universitas Indonesia Library
cover
Rambert, Glady Inri
"Kehamilan diketahui sebagai salah satu faktor risiko utama terjadinya tromboemboli baik di arteri maupun vena, yang bisa meningkat sebanyak 4 sampai 5 kali. Venografi merupakan baku emas untuk diagnosis DVT namun karena invasif, tidak dilakukan pada wanita hamil. Thrombin Anti Thrombin complex (TAT) dan D-dimer (DD) adalah pemeriksaan yang secara klinis berguna untuk prediksi dan diagnosis trombosis. Namun kadar TAT dan DD akan meningkat dalam situasi yang bervariasi termasuk kehamilan.
Penelitian ini bertujuan untuk mendapatkan gambaran kadar fibrin monomer pada kehamilan trimester 1, 2, dan 3. Terdapat 31 sampel masing-masing pada trimester 1, 2, dan 3. CV kontrol normal dan abnormal pemeriksaan fibrin monomer adalah 7.43% dan 3.51%. Kadar fibrin monomer menunjukkan distribusi tidak normal dengan nilai p = 0.001 (<0.05) sehingga data disajikan dalam nilai median dan nilai rentang. Berdasarkan nilai cutt off 6.0 μg/mL maka peningkatan kadar fibrin monomer dijumpai hanya pada trimester 3 yaitu sebesar 3.2%.
Tidak terdapat perbedaan yang bermakna antara trimester 1 dan 2 (p=0.491), sedangkan antara trimester 1 dan 3 berbeda bermakna (p=0.004), begitu juga antara trimester 2 dan 3 (p=0.031), sehingga dapat dikatakan fibrin monomer kadarnya pada kehamilan relatif tetap.

Background: Pregnancy is known as a risk factor for thromboembolism at arterial and venous, which could rise as much as 4 to 5 times .Venography is the gold standard for the diagnosis of DVT, but because it is invasive, so it is not done on pregnant women. Thrombin anti-thrombin complex (TAT) and D-dimer, which are the clinical examination useful for the prediction and diagnosis of thrombosis. However, the concentration of TAT and D-dimer will be increased in various conditions, including pregnancy.
Aim: This study is to gain preview on the fibrin monomer for the first, second and third trimester of pregnancy.
Methods: A cross sectional study. There was 31 samples, respectively the first, second and third trimester of pregnancy. CV of normal and abnormal control of fibrin monomer was 7.43% and 3.51 %. Levels of fibrin monomer showed the abnormal distribution, with p = 0.001 (> 0.05), so data are presented as median values and value ranges. Based on the cut-off value of 6 μg/mL, then increased levels of fibrin monomer was only found in third trimester , which was 3.2%.
Result: There were no significant differences between the first and the second trimester of pregnancy (p = 0.491). There were significant differences between the first and third trimester of pregnancy (p=0.004) as well as between the second and third of pregnancy (p=0.031). Thus, fibrin monomer level was relatively constant during pregnancy.
Conclusion: fibrin monomer is relatively constant during pregnancy compared to D-dimer.
"
Jakarta: Fakultas Kedokteran Universitas Indonesia, 2014
SP-Pdf
UI - Tugas Akhir  Universitas Indonesia Library